BR112015017903A2 - vacina de subunidade de mycobacterium avium subsp. paratuberculosis única ou de múltiplos estágios - Google Patents

vacina de subunidade de mycobacterium avium subsp. paratuberculosis única ou de múltiplos estágios

Info

Publication number
BR112015017903A2
BR112015017903A2 BR112015017903A BR112015017903A BR112015017903A2 BR 112015017903 A2 BR112015017903 A2 BR 112015017903A2 BR 112015017903 A BR112015017903 A BR 112015017903A BR 112015017903 A BR112015017903 A BR 112015017903A BR 112015017903 A2 BR112015017903 A2 BR 112015017903A2
Authority
BR
Brazil
Prior art keywords
paratuberculosis
avium subsp
mycobacterium avium
multistage
mycobacterium
Prior art date
Application number
BR112015017903A
Other languages
English (en)
Inventor
Thakur Aneesh
Aagaard Claus
Jungersen Gregers
MIKKELSEN Heidi
Lawaetz Andersen Peter
Original Assignee
Univ Danmarks Tekniske
Statens Seruminstitut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Danmarks Tekniske, Statens Seruminstitut filed Critical Univ Danmarks Tekniske
Publication of BR112015017903A2 publication Critical patent/BR112015017903A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Abstract

resumo “vacina de subunidade de mycobacterium avium subsp. paratuberculosis única ou de múltiplos estágios” a presente invenção proporciona um ou mais polipeptídeos imunogênicos para uso em uma vacina preventiva ou terapêutica contra infecção latente ou ativa em um ser humano ou animal causada pela espécie mycobacterium, por exemplo, mycobacterium avium subsp. paratuberculosis. adicionalmente a vacina única ou de múltiplas fases que compreende os um ou mais polipeptídeos imunogênicos é proporcionada para administração para a prevenção ou tratamento de infecção com a espécie mycobacterium, por exemplo, mycobacterium avium subsp. paratuberculosis. ademais, as vacinas de ácido nucleico, capazes de expressão in vivo da vacina de múltiplas fases que compreende os um ou mais polipeptídeos imunogênicos, é proporcionada para a prevenção ou o tratamento de infecção com a espécie mycobacterium, por exemplo, mycobacterium avium subsp. paratuberculosis. 1/1
BR112015017903A 2013-01-28 2014-01-28 vacina de subunidade de mycobacterium avium subsp. paratuberculosis única ou de múltiplos estágios BR112015017903A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13152908 2013-01-28
PCT/EP2014/051645 WO2014114812A1 (en) 2013-01-28 2014-01-28 A single or multistage mycobacterium avium subsp. paratuberculosis subunit vaccine

Publications (1)

Publication Number Publication Date
BR112015017903A2 true BR112015017903A2 (pt) 2017-11-21

Family

ID=47598744

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015017903A BR112015017903A2 (pt) 2013-01-28 2014-01-28 vacina de subunidade de mycobacterium avium subsp. paratuberculosis única ou de múltiplos estágios

Country Status (7)

Country Link
US (1) US20160228528A1 (pt)
EP (1) EP2948173A1 (pt)
JP (1) JP2016513078A (pt)
AU (1) AU2014209809A1 (pt)
BR (1) BR112015017903A2 (pt)
CA (1) CA2898418A1 (pt)
WO (1) WO2014114812A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3474889A4 (en) 2016-06-22 2020-04-29 International AIDS Vaccine Initiative, Inc. RECOMBINANT CYTOMEGALOVIRUS VECTORS AS VACCINE AGAINST TUBERCULOSIS
WO2019079155A1 (en) * 2017-10-17 2019-04-25 International Aids Vaccine Initiative, Inc. CASSETTES OF ANTIGENS OF TUBERCULOSIS
GB201718251D0 (en) * 2017-11-03 2017-12-20 Univ Sydney Vaccine Compositions
GB201811382D0 (en) * 2018-07-11 2018-08-29 Taylor John Hermon Vaccine
WO2020141207A1 (en) 2019-01-03 2020-07-09 Evaxion Biotech Aps Vaccines targeting neoepitopes
CA3131824A1 (en) 2019-03-11 2020-09-17 Birgitte Rono Nucleic acid vaccination using neo-epitope encoding constructs

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554101A (en) 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4599231A (en) 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
US4599230A (en) 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
US4608251A (en) 1984-11-09 1986-08-26 Pitman-Moore, Inc. LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues
NZ215865A (en) 1985-04-22 1988-10-28 Commw Serum Lab Commission Method of determining the active site of a receptor-binding analogue
WO1986006487A1 (en) 1985-04-22 1986-11-06 Commonwealth Serum Laboratories Commission Method for determining mimotopes
US4601903A (en) 1985-05-01 1986-07-22 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease
US7074559B2 (en) * 2002-03-06 2006-07-11 Refents of the University of Minnesota Mycobacterial diagnostics

Also Published As

Publication number Publication date
CA2898418A1 (en) 2014-07-31
JP2016513078A (ja) 2016-05-12
US20160228528A1 (en) 2016-08-11
EP2948173A1 (en) 2015-12-02
WO2014114812A1 (en) 2014-07-31
AU2014209809A1 (en) 2015-08-06

Similar Documents

Publication Publication Date Title
BR112018068748A2 (pt) composto, composição farmacêutica e de vacina, métodos para indução ou promoção de uma resposta imunológica, para tratamento de câncer, de doenças infecciosas, de distúrbios imunológicos e de doenças imunológicas e para tratamento ou prevenção de uma doença, e, uso de um composto
BR112015017903A2 (pt) vacina de subunidade de mycobacterium avium subsp. paratuberculosis única ou de múltiplos estágios
BR112017014209A2 (pt) design de aparelhos dentários auxiliado por sistema de computador
BR112017013891A2 (pt) composições imunogênicas para uso em vacinas pneumocócicas
BR112018016222A2 (pt) dispositivo de inserção de implante
AR089797A1 (es) Vacunas contra clostridum difficile que comprenden toxinas recombinantes
BR112016016290A2 (pt) Composições farmacêuticas de insulina de ação rápida, conjunto de infusão, sistema de conjunto de infusão e usos de análogos monoméricos ou diméricos de insulina
BR212016030926U2 (pt) conjugados de alvo e partículas e formulações dos mesmos
BR112012030337A2 (pt) vacinas compreendendo colesterol e cpg como moléculas veículo-adjuvante exclusivas e uso das mesmas
BR112015029144A2 (pt) formulações de gel para guiar radioterapia
BR112015022514A2 (pt) composições que compreendem selênio e uso das mesmas para o tratamento e prevenção de doença ou condições associadas à disfunção mitocondrial
BR112017000519A2 (pt) "composição imunogênica, e, método para proteger um mamífero contra uma infecção meningocócica"
AR099569A1 (es) Derivados de insulina y los usos médicos de estos
BR112016027043A8 (pt) combinação, composição farmacêutica compreendendo glucocorticoide e edo-s101, kit e uso no tratamento de câncer
BR112018015367A2 (pt) carreadores oromucosais de nanofibra para tratamento terapêutico
MX2017004772A (es) Composiciones y métodos para la administración fisiológica utilizando cannabidiol.
BR112016007620A2 (pt) composto, medicamento, e, uso de um composto
BR112015003851A2 (pt) composições compreendendo um domínio variável único e mesilato de camostato (cm)
BR112017002335A2 (pt) formulações de suspensão oral em pó de agentes antibacterianos
BR112017022755A2 (pt) formulações de glucopiranosil lipídeo a e alérgeno a amendoim para administração sublingual
ECSP16086247A (es) (s)-pirlindole y sus sales farmacéuticamente aceptables para uso en medicina
BR112016007390A8 (pt) Vacina de haemophilus parasuis sorotipo tipo quatro
BR112018008697A2 (pt) método e kit para vacinação contra um auto-antígeno, uso de um kit, e, vacina para uso em vacinação.
BR112017026834A2 (pt) composição compreendendo vitaminas b e vitaminas c e seu uso
BR112018071363A2 (pt) composições farmacêuticas orais de nicotinamida

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]